Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges

A Elbehiry, E Marzouk, M Aldubaib, A Abalkhail… - Antibiotics, 2023 - mdpi.com
Helicobacter pylori (H. pylori) infection, which affects approximately half of the world's
population, remains a serious public health problem. As H. pylori infection leads to a number …

Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis

TC Hong, EM El-Omar, YT Kuo, JY Wu… - The Lancet …, 2024 - thelancet.com
Background We previously showed rising primary antibiotic resistance of Helicobacter pylori
during 1990–2015 in the Asia-Pacific region. However, whether primary antibiotic resistance …

2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment

L Zhou, H Lu, Z Song, B Lyu, Y Chen, J Wang… - Chinese Medical …, 2022 - mednexus.org
Background: Helicobacter pylori (H. pylori) infection is an infectious disease with a
prevalence rate of up to 50% worldwide. It can cause indigestion, gastritis, peptic ulcer, and …

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European …

M Dinis-Ribeiro, M Areia, AC De Vries… - …, 2012 - thieme-connect.com
Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common
and are associated with an increased risk for gastric cancer. In the absence of guidelines …

Functional gastroduodenal disorders

J Tack, NJ Talley, M Camilleri, G Holtmann, P Hu… - Gastroenterology, 2006 - Elsevier
A numerically important group of patients with functional gastrointestinal disorders have
chronic symptoms that can be attributed to the gastroduodenal region. Based on the …

Probiotics—from Metchnikoff to bioactives

T Vasiljevic, NP Shah - International dairy journal, 2008 - Elsevier
The benefits of probiotics have been recognized and explored for over a century. The
pioneering work of Tissier and Moro was elaborated in the Metchnikoff's theory of longevity …

Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial

KF Pan, WQ Li, L Zhang, WD Liu, JL Ma, Y Zhang… - Nature Medicine, 2024 - nature.com
Gastric cancer is a leading cause of cancer-related deaths in China. Affecting more than
40% of the world's population, Helicobacter pylori is a major risk factor for gastric cancer …

Helicobacter pylori infection: a dynamic process from diagnosis to treatment

Q Sun, C Yuan, S Zhou, J Lu, M Zeng, X Cai… - Frontiers in cellular and …, 2023 - frontiersin.org
Helicobacter pylori, a gram-negative microaerophilic pathogen, causes several upper
gastrointestinal diseases, such as chronic gastritis, peptic ulcer disease, and gastric cancer …

Helicobacter pylori infection

P Malfertheiner, MC Camargo, E El-Omar… - Nature reviews Disease …, 2023 - nature.com
Helicobacter pylori infection causes chronic gastritis, which can progress to severe
gastroduodenal pathologies, including peptic ulcer, gastric cancer and gastric mucosa …

[HTML][HTML] Role of symptoms in diagnosis and outcome of gastric cancer

G Maconi, G Manes, GB Porro - World journal of gastroenterology …, 2008 - ncbi.nlm.nih.gov
Gastric cancer is one of the most common cancers and the second most common cause of
cancer deaths worldwide. Apart from Japan, where screening programmes have resulted in …